For many people, digestive side effects are most noticeable early on and while the dose is being increased, and they tend to ease as the body adjusts
Randomized research clinical trials will determine if GLP-1s can be beneficial in AUDs and other substance use disorders
Yesyour PlexusDx provider can slow your dose escalation or hold your current dose longer to allow better tolerance before increasing
These improvements result primarily from weight loss and enhanced metabolic parameters, leading to reduced hepatic steatosis and normalization of elevated transaminases
Semaglutide operates by mimicking the action of the incretin hormone GLP-1, enhancing insulin secretion, suppressing glucagon release, and slowing gastric emptying
Its prescribed when the patient needs a custom dose or formulation that is not commercially available